Abbott to Acquire St. Jude Medical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
S&P Affirms Negative Outlook on Abbott (ABT) Amid Move to Acquire St. Jude Medical (STJ)
April 28, 2016 11:38 AM EDTStandard & Poor's Ratings Services stated that its ratings on Abbott Laboratories (NYSE: ABT), including the 'A+' corporate credit and 'A-1+' commercial paper ratings, remain on CreditWatch with negative implications. The CreditWatch update follows Abbott's offer to acquire St. Jude Medical for roughly $31 billion (including $6 billion of assumed St. Jude debt). This transaction is in addition to the planned roughly $9 billion debt-funded acquisition of Alere.
"We believe that when completed, the acquisition of St. Jude Medical would significantly strengthen Abbott's position in the medical device industry as well as broaden its already very... More
Abbott (ABT), St. Jude (STJ) Deal Carries $685M Termination Fee
April 28, 2016 7:13 AM EDTAbbott (NYSE: ABT) filed the agreement terms of its proposed takeover of St. Jude Medical (NYSE: STJ). The following was noted on Thursday:
Section 10.03 Termination Fees.
(a) In the event that... More
